Table 2.
Allele Frequency |
Full Sample |
Study-Specific ORs (95% CI) |
||||||
---|---|---|---|---|---|---|---|---|
Allele | Resolved (n = 308) | Persistent (n = 624) | OR* (95% CI)* | P Value* | ACCESS‡ | SAGA‡ | HFH‡ | Phet |
01:02 | 0.064 | 0.046 | 0.63 (0.41–0.96) | 0.032 | –§ | 0.55 (0.30–1.02) | 0.75 (0.41–1.39) | 0.761 |
03:02 | 0.130 | 0.078 | 0.52 (0.37–0.72) | 1.3 × 10−4 | 0.27 (0.08–0.90) | 0.62 (0.38–0.99) | 0.46 (0.27–0.79) | 0.418 |
11:01 | 0.139 | 0.175 | 1.41 (1.04–1.91) | 0.028 | 4.16 (1.12–15.50) | 1.19 (0.77–1.83) | 1.53 (0.96–2.43) | 0.271 |
15:01 | 0.016 | 0.034 | 2.25 (1.07–4.74) | 0.033 | –§ | 3.16 (0.89–11.28) | 1.70 (0.65–4.45) | 0.507 |
For definition of abbreviations, see Table 1.
Associations with P < 0.05. Models were estimated using generalized estimating equations, and the allele odds ratios are estimated assuming a dominant model adjusted for sex and genome-wide percent African ancestry. P values were calculated using a Wald test.
Based on chest radiographs assessed after a minimum of 2 years of follow–up.
The study-specific sample sizes are as follows: ACCESS (n = 78; 24 resolved and 54 persistent), SAGA (n = 469; 142 resolved and 327 persistent), and HFH (n = 385; 142 resolved and 243 persistent).
Not estimable.